FGEN vs SWK · rev $29.6M vs P/E 34, rev $7.81B
FibroGen Inc (FGEN) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
FGEN currently screens at market cap $39.3M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the FGEN and SWK stock pages for the full models.
Not investment advice.